Delayed Prostate Cancer Therapy Monsey NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Norman Lester Rosen
(914) 965-2060
3333 Henry Hudson Way
Bronx, NY
GINO BOTTINO, MD
(914) 241-8866
400 E Main Street
Mount Kisco, NY
Basil Hilaris, MD
718-920-9750
600 E 233rd St
Bronx, NY
Jesse M Cedarbaum, MD
914-345-7436
777 Old Saw Mill River Rd
Tarrytown, NY
Dr.Richards Afonja
(973) 279-8100
476 Colfax Avenue
Clifton, NJ
Raquibul Hannan
(718) 405-8560
111 E 210th St
Bronx, NY
HERBERT EDLIS, MD
(718) 584-9000
130 W Kingsbridge Road
Bronx, NY
MATTHEW WEISSLER, MD
(914) 681-5200
210 Westchester Avenue
West Harrison, NY
Eric Lamar Saunders, MD
1200 E Ridgewood Ave
Ridgewood, NJ
Eli Kirshner, MD
400 Old Hook Rd
Westwood, NJ
Data Provided by:
        

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Lung Cancer Monsey NY
Taking a combination form of hormone replacement therapy, which includes both estrogen and progestin, increases a woman's risk for dying from lung cancer, a new study has found. The finding stems from an analysis of data from the Women's Health Initiative trial on 16,608 postmenopausal women, aged 50 to 79, in the United States who had been randomly assigned to take either a once-daily tablet of 0.625 milligrams conjugated equine estrogen plus 2.5 mg medroxyprogesterone acetate or a placebo.
- Open Prostatectomy Versus Laparoscopic Procedure Monsey NY
- Hormone Therapy for Prostate Cancer Monsey NY
- Exercise for Prostate Cancer Monsey NY
- Hormone Therapy for Breast Cancer Monsey NY
- Drug Combo Proves Powerful Against Lung Cancer Monsey NY
- Hormone Therapy for Early Prostate Cancer Monsey NY
- Attack Of The Cancer Fighting Tomatoes Monsey NY
- Head and Neck Cancer Treatment Monsey NY
- Diagnosis of Prostate Cancer Monsey NY